214 related articles for article (PubMed ID: 16607275)
1. Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development.
Sung YM; He G; Hwang DH; Fischer SM
Oncogene; 2006 Sep; 25(40):5507-16. PubMed ID: 16607275
[TBL] [Abstract][Full Text] [Related]
2. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.
Sung YM; He G; Fischer SM
Cancer Res; 2005 Oct; 65(20):9304-11. PubMed ID: 16230392
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin.
Ansari KM; Sung YM; He G; Fischer SM
Carcinogenesis; 2007 Oct; 28(10):2063-8. PubMed ID: 17277233
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression.
Surh I; Rundhaug J; Pavone A; Mikulec C; Abel E; Fischer SM
Mol Carcinog; 2011 Jun; 50(6):458-68. PubMed ID: 21268127
[TBL] [Abstract][Full Text] [Related]
5. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.
Brouxhon S; Kyrkanides S; O'Banion MK; Johnson R; Pearce DA; Centola GM; Miller JN; McGrath KH; Erdle B; Scott G; Schneider S; VanBuskirk J; Pentland AP
Cancer Res; 2007 Aug; 67(16):7654-64. PubMed ID: 17699770
[TBL] [Abstract][Full Text] [Related]
6. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
7. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
[TBL] [Abstract][Full Text] [Related]
9. The effect of cyclooxygenase-2 overexpression on skin carcinogenesis is context dependent.
Rundhaug JE; Pavone A; Kim E; Fischer SM
Mol Carcinog; 2007 Dec; 46(12):981-92. PubMed ID: 17583568
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E receptor EP3 deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis.
Shoji Y; Takahashi M; Takasuka N; Niho N; Kitamura T; Sato H; Maruyama T; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K
Carcinogenesis; 2005 Dec; 26(12):2116-22. PubMed ID: 16051640
[TBL] [Abstract][Full Text] [Related]
11. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses.
Meeran SM; Vaid M; Punathil T; Katiyar SK
Carcinogenesis; 2009 Mar; 30(3):520-8. PubMed ID: 19158151
[TBL] [Abstract][Full Text] [Related]
12. The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
He G; Muga S; Thuillier P; Lubet RA; Fischer SM
Mol Carcinog; 2005 Aug; 43(4):198-206. PubMed ID: 15864802
[TBL] [Abstract][Full Text] [Related]
13. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
[TBL] [Abstract][Full Text] [Related]
14. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
[TBL] [Abstract][Full Text] [Related]
15. The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia.
Chang SH; Ai Y; Breyer RM; Lane TF; Hla T
Cancer Res; 2005 Jun; 65(11):4496-9. PubMed ID: 15930264
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C
Carcinogenesis; 2003 Jun; 24(6):1123-32. PubMed ID: 12807749
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.
Budunova IV; Kowalczyk D; Pérez P; Yao YJ; Jorcano JL; Slaga TJ
Oncogene; 2003 May; 22(21):3279-87. PubMed ID: 12761498
[TBL] [Abstract][Full Text] [Related]
18. Pro/antioxidant status and AP-1 transcription factor in murine skin following topical exposure to cumene hydroperoxide.
Murray AR; Kisin ER; Kommineni C; Vallyathan V; Castranova V; Shvedova AA
Carcinogenesis; 2007 Jul; 28(7):1582-8. PubMed ID: 17234724
[TBL] [Abstract][Full Text] [Related]
19. Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse.
Mustacich D; Wagner A; Williams R; Bair W; Barbercheck L; Stratton SP; Bhattacharyya AK; Powis G
Carcinogenesis; 2004 Oct; 25(10):1983-9. PubMed ID: 15166090
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members.
Wach S; Schirmacher P; Protschka M; Blessing M
Oncogene; 2001 Nov; 20(53):7761-9. PubMed ID: 11753654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
